DANIELLE BULL: Open Payments
NPI 1598207466 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,857 in 30 payments from 10 companies in 2025. Trend: 2023 $152 · 2024 $653 · 2025 $3,857
Consulting: $1,535Speaker / faculty: $1,290Food & beverage: $990Travel & lodging: $42
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $1,705 |
| SANOFI-AVENTIS U.S. LLC | 12 | $1,619 |
| Alexion Pharmaceuticals, Inc. | 1 | $175 |
| Incyte Corporation | 2 | $147 |
| Amgen Inc. | 1 | $98 |
| GENZYME CORPORATION | 2 | $39 |
| Astellas Pharma US Inc | 1 | $30 |
| SOBI, INC | 1 | $20 |
| Genentech USA, Inc. | 1 | $15 |
| Janssen Scientific Affairs, LLC | 1 | $8 |
Products named: REZUROCK, TALVEY, ULTOMIRIS, NIKTIMVO, BLINCYTO, RYBREVANT, SARCLISA, Cresemba.
Industry payments across PA — which companies pay providers there.
